These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32383349)

  • 1. Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients.
    Marcondes-Braga FG; Gioli-Pereira L; Bernardez-Pereira S; Batista GL; Mangini S; Issa VS; Fernandes F; Bocchi EA; Ayub-Ferreira SM; Mansur AJ; Gutz IGR; Krieger JE; Pereira AC; Bacal F
    ESC Heart Fail; 2020 Aug; 7(4):1744-1752. PubMed ID: 32383349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Exhaled Breath Acetone in the Prognosis of Patients with Heart Failure with Reduced Ejection Fraction (HFrEF). One Year of Clinical Follow-up.
    Marcondes-Braga FG; Batista GL; Gutz IG; Saldiva PH; Mangini S; Issa VS; Ayub-Ferreira SM; Bocchi EA; Pereira AC; Bacal F
    PLoS One; 2016; 11(12):e0168790. PubMed ID: 28030609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled acetone as a new biomaker of heart failure severity.
    Marcondes-Braga FG; Gutz IGR; Batista GL; Saldiva PHN; Ayub-Ferreira SM; Issa VS; Mangini S; Bocchi EA; Bacal F
    Chest; 2012 Aug; 142(2):457-466. PubMed ID: 22345382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled Acetone Concentration Is Related to Hemodynamic Severity in Patients With Non-Ischemic Chronic Heart Failure.
    Yokokawa T; Sugano Y; Shimouchi A; Shibata A; Jinno N; Nagai T; Kanzaki H; Aiba T; Kusano K; Shirai M; Takeishi Y; Yasuda S; Ogawa H; Anzai T
    Circ J; 2016 Apr; 80(5):1178-86. PubMed ID: 27026173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breath analysis combined with cardiopulmonary exercise testing and echocardiography for monitoring heart failure patients: the AEOLUS protocol.
    Biagini D; Pugliese NR; Vivaldi FM; Ghimenti S; Lenzi A; De Angelis F; Ripszam M; Bruderer T; Armenia S; Cappeli F; Taddei S; Masi S; Francesco FD; Lomonaco T
    J Breath Res; 2023 Aug; 17(4):. PubMed ID: 37524075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breath acetone concentration: too heterogeneous to constitute a diagnosis or prognosis biomarker in heart failure? A systematic review and meta-analysis.
    Gouzi F; Ayache D; Hédon C; Molinari N; Vicet A
    J Breath Res; 2021 Nov; 16(1):. PubMed ID: 34727537
    [No Abstract]   [Full Text] [Related]  

  • 7. Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure.
    Yokokawa T; Sato T; Suzuki S; Oikawa M; Yoshihisa A; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Shimouchi A; Takeishi Y
    Int Heart J; 2018 Jul; 59(4):808-812. PubMed ID: 29794390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exhaled Breath Analysis Using Selected Ion Flow Tube Mass Spectrometry and Disease Severity in Heart Failure.
    Tang WHW; Tranchito L; Albert C; Gul ZG; Cikach FS; Grove D; Wu Y; Dweik RA
    Metabolites; 2023 Oct; 13(10):. PubMed ID: 37887374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change of Exhaled Acetone Concentration in a Diabetic Patient with Acute Decompensated Heart Failure.
    Yokokawa T; Ichijo Y; Houtsuki Y; Matsumoto Y; Oikawa M; Yoshihisa A; Sugimoto K; Nakazato K; Suzuki H; Saitoh SI; Shimouchi A; Takeishi Y
    Int Heart J; 2017 Oct; 58(5):828-830. PubMed ID: 28966328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
    Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
    J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.
    Fudim M; Ambrosy AP; Sun JL; Anstrom KJ; Bart BA; Butler J; AbouEzzeddine O; Greene SJ; Mentz RJ; Redfield MM; Reddy YNV; Vaduganathan M; Braunwald E; Hernandez AF; Borlaug BA; Felker GM
    J Am Heart Assoc; 2018 Dec; 7(24):e010364. PubMed ID: 30561266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
    Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
    Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated exhaled acetone concentration in stage C heart failure patients with diabetes mellitus.
    Yokokawa T; Sato T; Suzuki S; Oikawa M; Yoshihisa A; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Shimouchi A; Takeishi Y
    BMC Cardiovasc Disord; 2017 Nov; 17(1):280. PubMed ID: 29145814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of acute decompensated heart failure evaluated by series of exhaled acetone concentrations as noninvasive biomarker of heart failure severity.
    Yokokawa T; Sugano Y; Shimouchi A; Shibata A; Nakayama T; Ohara T; Jinno N; Kanzaki H; Anzai T
    Int J Cardiol; 2016 Feb; 204():112-3. PubMed ID: 26655553
    [No Abstract]   [Full Text] [Related]  

  • 17. Exhaled Breath Analysis in Heart Failure.
    Marcondes-Braga FG; Batista GL; Bacal F; Gutz I
    Curr Heart Fail Rep; 2016 Aug; 13(4):166-71. PubMed ID: 27287200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and prognosis of patients admitted for heart failure: A 5-year retrospective study of African patients.
    Bonsu KO; Owusu IK; Buabeng KO; Reidpath DD; Kadirvelu A
    Int J Cardiol; 2017 Jul; 238():128-135. PubMed ID: 28318656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M
    J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosis marker syndecan-1 and outcome in patients with heart failure with reduced and preserved ejection fraction.
    Tromp J; van der Pol A; Klip IT; de Boer RA; Jaarsma T; van Gilst WH; Voors AA; van Veldhuisen DJ; van der Meer P
    Circ Heart Fail; 2014 May; 7(3):457-62. PubMed ID: 24647119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.